Skip to Content


Printer-friendly Send by email PDF version
  • October 2, 2015

    UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.

    “Bleeding is the number one killer of young people, and maternal death from postpartum hemorrhage can be as high as one in 50 births in low resource settings so these are extreme problems,” explains Christian Kastrup, an assistant professor in the Department of Biochemistry and Molecular Biology and the Michael Smith Laboratories at the...

  • September 30, 2015

    New research by scientists at UBC and BC Children’s Hospital finds that infants can be protected from getting asthma if they acquire four types of gut bacteria by three months of age. More than 300 families from across Canada participated in this research through the Canadian Healthy Infant Longitudinal Development (CHILD) Study.

    “This research supports the hygiene hypothesis that we’re making our environment too clean. It shows that gut bacteria play a role in asthma, but it is early in life when the baby’s immune system is being established,” said the...

  • September 18, 2015

    Congratulations to Dr. Joerg Bohlmann for being inducted into the Fellows of the Royal Society of Canada (RSC) in the Life Science Division!  This is the highest honour a scholar can achieve in the arts, humanities and sciences in Canada.

    Dr. Bohlmann is a world leader in the fields of plant and forestry genomics and in plant natural products biology.  He is distinguished for his research on the genomics of defense and resistance mechanisms of conifers against insect pests and insect-associated fungal pathogens, as well as on plant terpenoid biochemistry.  New systems...

  • August 4, 2015

    UBC scientists have opened the doors to new research into malnutrition by creating an animal model that replicates the imbalance of gut bacteria associated with the difficult-to-treat disease.

    Malnutrition affects millions of people worldwide and is responsible for one-fifth of deaths in children under the age of five. Children can also experience impaired cognitive development and stunted growth.

    The problem arises when people don’t have...

  • April 23, 2015

    Discovery paves way for treatments to prevent brain damage or death following head trauma

    A team of UBC researchers has made a significant discovery uncovering the cause of brain swelling after trauma to the head. Their research, published today in Cell, paves the way for a preventative drug treatment for severe brain damage following stroke, infection, head injury or cardiac arrest.

    By turning off a single gene, scientists from the Djavad...

  • April 1, 2015

    The work of the Bohlmann Lab on the mountain pine beetle genome was featured in an article in the April 2015 issue of National Geographic Magazine.  Read The Bug That’s Eating the Woods to find out more about the pine beetle epidemic.

  • February 6, 2015

    The Honourable Rona Ambrose, Minister of Health, on behalf of her colleague, the Honourable Ed Holder, Minister of State (Science and Technology), today announced that GlycoNet, a new national research network, is receiving $27.3 million over five years to develop new drugs and vaccines for conditions such as influenza, genetic diseases and diabetes.

    GlycoNet will build on Canada's international leadership in glycomics during the last 50 years. GlycoNet researchers will analyze the function of glycomes (or carbohydrates) in the body and find ways to take advantage of their...

  • November 28, 2014

    Research investigates use of biomass resources to replace petrochemicals

    The University of British Columbia is part of a new research initiative aimed at upgrading the sustainability of Canada’s industrial sector by replacing its lifeblood — petrochemicals — with green alternatives.

    UBC, Concordia University and the University of Toronto make up the Industrial Biocatalysis Network (IBN). The creation of IBN was announced today by the Natural Sciences and Engineering Research Council of Canada (NSERC). It is a five-year, $5 million program, part of the federal government’s...

  • November 17, 2014

    A new Canadian research network to study rare diseases and how genetic mutations cause these diseases will be established with a $2.3 million grant from the Canadian Institutes for Health Research (CIHR).

    The Canadian Rare Diseases Models and Mechanisms (RDMM) Network is led by Philip Hieter, a Professor of Medical Genetics, along with Kym Boycott, senior scientist at the Children’s Hospital of Eastern Ontario (CHEO), and Janet Rossant, senior scientist at The Hospital for Sick Children (SickKids).

    The network...

  • October 22, 2014

    A new finding by UBC Centre for Blood Research scientist Wilf Jefferies and his collaborators, demonstrates that T-Lymphocytes, a type of immune cell that learns to recognize and attack microbial pathogens and cancer, are activated by the TRPV1 pain receptor. The study entitle “TRPV1 channel regulates CD4+ T cell activation and pro-inflammatory properties” was published in ...

Syndicate content